Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma: A Phase II Trial

NCT04594772 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT04594772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04594772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma: A Phase II Trial
Lead sponsor
University of Cincinnati
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 17, 2021
Completion date
June 1, 2027
Enrollment
32 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas cancer